Eye viscosity increases with age

Article

According to a paper published in Clinical and Experimental Ophthalmology, loss of energy due to elastic hysteresis positively correlates with age, leading to the belief that eye viscosity increases with age.

According to a paper published in Clinical and Experimental Ophthalmology, loss of energy due to elastic hysteresis positively correlates with age, leading to the belief that eye viscosity increases with age.

Dr K. Ishii et al., Department of Ophthalmology, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Tokyo, Japan, included 24 eyes of 24 normal human patients in a prospective case series.

The non-contact tonometry procedure was conducted with a high-speed camera. The outcome measures were central corneal thickness (CCT), corneal thickness at 4 mm from the centre, corneal curvature and anterior chamber depth (ACD). IOP was also recorded using Goldmann applanation tonometry (GAT) and dynamic contour tonometer (DCT). The primary outcome measure was energy loss due to elastic hysteresis.

Mean CCT was 552.5 ± 36.1 µm, mean corneal curvature was 7.84 ± 0.26 mm and ACD was 2.83 ± 0.29 mm. Mean GAT-IOP was calculated as 14.2 ± 2.7 mmHg and DCT-IOP was 16.3 ± 3.5 mmHg.

The mean loss of energy due to elastic hysteresis was 3.90 × 10(-6) ± 2.49 × 10(-6) Nm and this was significantly linked to age, regardless of anterior eye structure or IOP.

The abstract for this study can be found here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.